MedTrace Logo

Predicitve Use of Spot Urine Protein/Creatinine Ratios in Preeclampsia

NCT00870428 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 117

Last updated 2009-03-27

No results posted yet for this study

Summary

The investigators intend to perform a large prospective study looking at the predictability of the random urine protein-to-creatinine ratio compared to the gold standard 24-hour urine protein collection. Furthermore, the investigators plan to investigate whether analysis of proteinuria at shorter time intervals (4 and 8 hours) within the overall 24-hour collection period is predictive of the 24-hour sample. Lastly, the investigators plan to determine whether a combination of the random test with a shorter collection interval is comparable to the 24-hour collection.

Conditions

Sponsors & Collaborators

  • University of California, Irvine

    collaborator OTHER

  • MemorialCare

    lead OTHER

Principal Investigators

  • Deborah Wing, MD · Univeristy of California Irvine

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00870428 on ClinicalTrials.gov